Plasma apelin: A novel biomarker for predicting diabetes

Clinica Chimica Acta

Volumn 435, Issue , 2014, Pages 18-23

  Ma, Wen Ya ^a   Yu, Tse Ya ^b   Wei, Jung Nan ^c   Hung, Chi Sheng ^d   Lin, Mao Shin ^d   Liao, Ying Jhu ^d   Pei, Dee ^a   Su, Ching Chieh ^a   Lu, Kuo Cheng ^a   Liu, Pi Hua ^e   Lin, Cheng Hsin ^d   Chuang, Lee Ming ^d,f,g   Kao, Hsien Li ^d   Lin, Jou Wei ^d   Chuang, Ya Ju ^d   Li, Hung Yuan ^d  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b EN CHU KONG HOSPITAL   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apelin; Biomarker; Diabetes; Predict

Indexed keywords

APELIN; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

EID: 84899965407     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.03.030     Document Type: Article

References (27)

1. Tatemoto K., Hosoya M., Habata Y., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251:471-476.
2. Boucher J., Masri B., Daviaud D., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146:1764-1771.
3. Japp A.G., Cruden N.L., Barnes G., et al. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 2010, 121:1818-1827.
4. O'Dowd B.F., Heiber M., Chan A., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136:355-360.
5. Sorhede Winzell M., Magnusson C., Ahren B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 2005, 131:12-17.
6. Ringstrom C., Nitert M.D., Bennet H., et al. Apelin is a novel islet peptide. Regul Pept 2010, 162:44-51.
7. Dray C., Knauf C., Daviaud D., et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008, 8:437-445.
8. Dray C., Debard C., Jager J., et al. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab 2010, 298:E1161-E1169.
9. Yue P., Jin H., Aillaud M., et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 2010, 298:E59-E67.
10. Attane C., Daviaud D., Dray C., et al. Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. J Mol Endocrinol 2011, 46:21-28.
11. Xu S., Han P., Huang M., et al. In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake. Peptides 2012, 37:320-326.
12. Attane C., Foussal C., Le Gonidec S., et al. Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 2012, 61:310-320.
13. Castan-Laurell I., Dray C., Knauf C., Kunduzova O., Valet P. Apelin, a promising target for type 2 diabetes treatment?. Trends Endocrinol Metab 2012, 23:234-241.
14. Li L., Yang G., Li Q., et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006, 114:544-548.
15. Erdem G., Dogru T., Tasci I., Sonmez A., Tapan S. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008, 116:289-292.
16. Zhang Y., Shen C., Li X., et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care 2009, 32:e150.
17. Li H.Y., Lin M.S., Wei J.N., et al. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects. Clin Chim Acta 2009, 403:97-101.
18. Li H.Y., Wei J.N., Lin M.S., et al. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta 2009, 404:149-153.
19. Hung C.S., Lee P.C., Li H.Y., et al. Haemoglobin A1c is associated with carotid intima-media thickness in a Chinese population. Clin Endocrinol (Oxf) 2011, 75:780-785.
20. Li H.Y., Lin M.S., Shih S.R., et al. The performance of risk scores and hemoglobin A1c to find undiagnosed diabetes with isolated postload hyperglycemia. Endocr J 2011, 58:441-448.
21. Ma W.Y., Yang C.Y., Shih S.R., et al. Measurement of waist circumference: midabdominal or iliac crest?. Diabetes Care 2013, 36:1660-1666.
22. ADA Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
23. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
24. Little R.R., Rohlfing C.L., Wiedmeyer H.M., Myers G.L., Sacks D.B., Goldstein D.E. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001, 47:1985-1992.
25. Reinehr T., Woelfle J., Roth C.L. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis. Metabolism 2011, 60:1349-1354.
26. Kawamata Y., Habata Y., Fukusumi S., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001, 1538:162-171.
27. De Mota N., Lenkei Z., Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000, 72:400-407.